The FDA may be making changes to how it handles COVID-19 booster shots. The agency’s top official says they’re taking a ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The project is dedicated to safeguarding US vaccine use so that it remains grounded in the best available science, free from ...

In this week’s edition of InnovationRx, we look at a patent fight over the world’s top-selling drug, breakthroughs from the American Association for Cancer Research, Verily’s Parkinson’s dataset, the ...

GSK plc GSK reported first-quarter 2025 core earnings of $1.13 per American depositary share (ADS), which beat the Zacks ...

As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the ...

Amid sweeping budget cuts and layoffs, HHS Secretary Robert F. Kennedy Jr. is planning a $20 million ad campaign urging ...

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

Public health experts worried about the future of vaccination in the US have come together in an unprecedented new initiative ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

In an interview with Dr. Phil, the Kennedy offered false information about vaccine oversight and revealed a lack of understanding of new drug approvals.

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.